Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 200   

Articles published

PFE 30.25 0.00 (0.00%)
price chart
Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca
Pfizer Inc., the world's biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, according to two people familiar with the matter.
Pfizer Looking For Another Mega-Merger � This Time With AstraZeneca  Bidness Etc
Report: Pfizer approached AstraZeneca about purchase  The News Journal
Related articles »  
Large Cap Active Runners: Facebook Inc (NASDAQ:FB), Pfizer Inc. (NYSE:
Facebook Inc (NASDAQ:FB) users in the U.S. will soon be able to see which of their friends are in close proximity using a new feature the company is launching on Thursday. Facebook Inc (NASDAQ:FB) shares after opening at $59.30 moved to $60.58 on last ...
Related articles »  
Pfizer Inc. (NYSE:PFE): Breakthroughs in Vaccines and Oncology
Tomahawk, WI 03/27/2014 (Basicsmedia) - While Pfizer Inc. (NYSE:PFE) got some bad news when its Celebrex patent was invalidated by a U.S.
Company Update: Pfizer Inc (NYSE:PFE) � Teva settles patent suit with Pfizer ...
Pfizer Inc (NYSE:PFE) [Reuters] - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. A U.S. court in March invalidated a patent ...
Teva, Pfizer settle patent lawsuit over blockbuster painkiller  Reuters
Teva Settles Patent Litigation with Pfizer on Celebrex(R)  Wall Street Journal
Related articles »  
Pfizer Inc. (NYSE:PFE): Potential New Oncology Therapy
Pfizer Inc. (NYSE:PFE) announced in early February some positive results from a randomized Phase 2 trial of palbociclib in combination with letrozole (for blocking the synthesis of estrogen) in post-menopausal women with estrogen receptor (ER) positive ...
Healthcare Watch List: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD ...
Pfizer Inc. (NYSE:PFE), the world's biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, according to two people familiar with the matter.
Related articles »  
Stocks Hot In News: Pfizer Inc. (NYSE:PFE), AstraZeneca plc (NYSE:AZN ...
US pharmaceutical giant Pfizer Inc. (NYSE:PFE) is reported to have made a tentative $101-billion (�60 billion) takeover offer for British rival AstraZeneca Plc, according to a media report.
Trending Stocks: Weibo Corp (ADR) (NASDAQ:WB), AstraZeneca (NYSE:AZN ...  Tech News
US Hot Stocks: AstraZeneca (NYSE:AZN), Barrick Gold (NYSE:ABX), Kraft Foods ...  Technology Perk
Related articles »  
Pfizer Inc. (NYSE:PFE)'s: Breast Cancer Drug Slowing Tumor Progression
Dallas, Texas, 04/15/2014 (ustrademedia) - Recent test studies have shown that experimental breast cancer drugs from Pfizer Inc. (NYSE:PFE) have the capacity to slow or halt the progression of advanced tumors. This should be a great addition as a form ...
Pfizer Price Target Lowered to $36.00 at Jefferies Group (PFE)  WKRB News
Jefferies Group Lowers Pfizer Price Target to $36.00 (PFE)  Zolmax
Related articles »  
Wall Street Breakfast: Must-Know News
Pfizer took a flyer at acquiring AstraZeneca (AZN) with a tentative offer to land the company in a deal worth over $100.7B.
Asia Pacific Market: Shares closed mixed in light trading  Business Standard
Related articles »  
Why Questcor Is Soaring Today While Pfizer Is Down
Pfizer Inc. (PFE) announced yesterday that its phase 2 randomized study, PALOMA-1, of palbociclib combined with letrozole, achieved its primary endpoint.
How Pfizer Inc. (NYSE:PFE) and Questcor Pharmaceuticals (NASDAQ:QCOR ...  iStreetWire
Buzz Stocks: Yahoo! Inc., Potash Corp./Saskatchewan (USA), Questcor ...  Schaeffers Research (blog)
Related articles »